Liu J, Li Y, Li Q, Liang D, et al. Biomarkers of response to camrelizumab combined with apatinib: an analysis from a phase II trial in advanced triple-negative breast cancer patients. Breast Cancer Res Treat 2021 Feb 25. pii: 10.1007/s10549-021-06128.
PMID: 33634417